205 related articles for article (PubMed ID: 23714504)
21. Secondary immunodeficiency in lymphoproliferative malignancies.
Friman V; Winqvist O; Blimark C; Langerbeins P; Chapel H; Dhalla F
Hematol Oncol; 2016 Sep; 34(3):121-32. PubMed ID: 27402426
[TBL] [Abstract][Full Text] [Related]
22. Bone marrow aspirates as part of routine donor assessment for allogeneic blood and marrow transplantation can reveal presence of occult hematological malignancies in otherwise asymptomatic individuals.
Kiss TL; Chang H; Daly A; Messner HA; Jamal N; Spaner D; Rubin S; Lipton JH
Bone Marrow Transplant; 2004 Apr; 33(8):855-8. PubMed ID: 14990983
[TBL] [Abstract][Full Text] [Related]
23. Precision medicine and novel molecular target therapies in acute myeloid leukemia: the background of hematologic malignancies (HM)-SCREEN-Japan 01.
Miyamoto K; Minami Y
Int J Clin Oncol; 2019 Aug; 24(8):893-898. PubMed ID: 31111287
[TBL] [Abstract][Full Text] [Related]
24. Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant.
Alyea EP; Soiffer RJ; Canning C; Neuberg D; Schlossman R; Pickett C; Collins H; Wang Y; Anderson KC; Ritz J
Blood; 1998 May; 91(10):3671-80. PubMed ID: 9573003
[TBL] [Abstract][Full Text] [Related]
25. Reliable engraftment, low toxicity, and durable remissions following allogeneic blood stem cell transplantation with minimal conditioning.
Kobbe G; Schneider P; Aivado M; Zohren F; Schubert D; Fenk R; Neumann F; Kronenwett R; Pape H; Rong A; Royer-Pokora B; Hildebrandt B; Germing U; Gattermann N; Heyll A; Haas R
Exp Hematol; 2002 Nov; 30(11):1346-53. PubMed ID: 12423689
[TBL] [Abstract][Full Text] [Related]
26. Trends in hematological cancer in the elderly in Denmark, 1980-2012.
Ocias LF; Larsen TS; Vestergaard H; Friis LS; Abildgaard N; Frederiksen H;
Acta Oncol; 2016; 55 Suppl 1():98-107. PubMed ID: 26783877
[TBL] [Abstract][Full Text] [Related]
27. Evolution of treatment strategies in chronic lymphocytic leukemia. Part 2 of a 3-Part series: Advances in the treatment of hematologic malignancies.
Keating MJ; Rai KR; Wierda WG
Clin Adv Hematol Oncol; 2005 Aug; 3(8):1-10; quiz 11-2. PubMed ID: 16201050
[TBL] [Abstract][Full Text] [Related]
28. Are we curing more older adults with acute myeloid leukemia with allogeneic transplantation in CR1?
Finn LE; Foran JM
Curr Opin Hematol; 2016 Mar; 23(2):95-101. PubMed ID: 26825695
[TBL] [Abstract][Full Text] [Related]
29. Leukemias and myeloma.
Wiernik PH
Cancer Chemother Biol Response Modif; 1988; 10():129-47. PubMed ID: 3079381
[No Abstract] [Full Text] [Related]
30. Geriatric Assessment in Acute Myeloid Leukemia.
Woods JD; Klepin HD
Acta Haematol; 2024; 147(2):219-228. PubMed ID: 38035561
[TBL] [Abstract][Full Text] [Related]
31. Management of hematologic malignancies in the elderly: 15-year experience at the Aviano Cancer Center, Italy.
Zagonel V; Monfardini S; Tirelli U; Carbone A; Pinto A
Crit Rev Oncol Hematol; 2001 Sep; 39(3):289-305. PubMed ID: 11500269
[TBL] [Abstract][Full Text] [Related]
32. Reduced-intensity conditioning followed by related allografts in hematologic malignancies: long-term outcomes most successful in indolent and aggressive non-Hodgkin lymphomas.
Warlick ED; Tomblyn M; Cao Q; Defor T; Blazar BR; Macmillan M; Verneris M; Wagner J; Dusenbery K; Aurora M; Bachanova V; Brunstein C; Burns L; Cooley S; Kaufman D; Majhail NS; McClune B; McGlave P; Miller J; Oran B; Slungaard A; Vercellotti G; Weisdorf DJ
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1025-32. PubMed ID: 21047561
[TBL] [Abstract][Full Text] [Related]
33. An experience with sixty cases of haematological malignancies; a clinico haematological correlation.
Idris M; Shah SH; Fareed J; Gul N
J Ayub Med Coll Abbottabad; 2004; 16(4):51-4. PubMed ID: 15762065
[TBL] [Abstract][Full Text] [Related]
34. Liquid tumors in the elderly.
Mato A; Feldman T; Richter J; Siegel DS; Goy A
Clin Geriatr Med; 2012 Feb; 28(1):115-52. PubMed ID: 22326039
[No Abstract] [Full Text] [Related]
35. How Genetics Can Drive Initial Therapy Choices for Older Patients with Acute Myeloid Leukemia.
Moore JW; Torres N; Superdock M; Mendler JH; Loh KP
Curr Treat Options Oncol; 2022 Aug; 23(8):1086-1103. PubMed ID: 35687257
[TBL] [Abstract][Full Text] [Related]
36. Tailoring Therapy in Older Adults With Hematologic Malignancies.
Mangan BL; DuMontier C; Hopkins JO; Abel GA; McCurdy SR
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432220. PubMed ID: 38788182
[TBL] [Abstract][Full Text] [Related]
37. Chronic Lymphocytic Leukemia in the Elderly: Epidemiology and Proposed Patient-Related Approach.
Balducci L; Dolan D
Cancer Control; 2015 Oct; 22(4 Suppl):3-6. PubMed ID: 26618340
[TBL] [Abstract][Full Text] [Related]
38. Emerging therapeutic modalities for acute myeloid leukemia (AML) in older adults.
Huang LW; Olin RL
J Geriatr Oncol; 2017 Nov; 8(6):417-420. PubMed ID: 28835351
[TBL] [Abstract][Full Text] [Related]
39. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
[TBL] [Abstract][Full Text] [Related]
40. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
